CN114729015B - 具有抗衰老效果的多肽及其用途 - Google Patents

具有抗衰老效果的多肽及其用途 Download PDF

Info

Publication number
CN114729015B
CN114729015B CN202080066579.5A CN202080066579A CN114729015B CN 114729015 B CN114729015 B CN 114729015B CN 202080066579 A CN202080066579 A CN 202080066579A CN 114729015 B CN114729015 B CN 114729015B
Authority
CN
China
Prior art keywords
composition
skin
peptide
cells
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080066579.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN114729015A (zh
Inventor
奥克塔维欧·法兰珂
威廉·法里亚斯·波尔托
艾雷斯桑卓·佐纳里
卡洛里纳·雷斯·德·奥利维拉
艾德葛·安卓司·欧乔亚
朱利亚纳·洛特·德·卡尔法荷
里尔·布雷斯
马里亚纳·波罗尼
米利恩奈斯·关安
席伟尼·德·艾蓝卡尔·席尔法
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brazilian Catholic Education Union
Catholic University Of Brasilia
First Beauty Co
Original Assignee
Brazilian Catholic Education Union
Catholic University Of Brasilia
First Beauty Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brazilian Catholic Education Union, Catholic University Of Brasilia, First Beauty Co filed Critical Brazilian Catholic Education Union
Publication of CN114729015A publication Critical patent/CN114729015A/zh
Application granted granted Critical
Publication of CN114729015B publication Critical patent/CN114729015B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A61K47/551—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
CN202080066579.5A 2019-07-22 2020-07-22 具有抗衰老效果的多肽及其用途 Active CN114729015B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962877164P 2019-07-22 2019-07-22
US62/877,164 2019-07-22
PCT/US2020/043033 WO2021016330A2 (en) 2019-07-22 2020-07-22 Polypeptides having anti-senescent effects and uses thereof

Publications (2)

Publication Number Publication Date
CN114729015A CN114729015A (zh) 2022-07-08
CN114729015B true CN114729015B (zh) 2024-01-12

Family

ID=74194270

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080066579.5A Active CN114729015B (zh) 2019-07-22 2020-07-22 具有抗衰老效果的多肽及其用途

Country Status (10)

Country Link
US (3) US12268746B2 (enExample)
EP (1) EP4004021B1 (enExample)
JP (2) JP2022541845A (enExample)
KR (1) KR20230096914A (enExample)
CN (1) CN114729015B (enExample)
BR (1) BR112022001229A2 (enExample)
ES (1) ES3049051T3 (enExample)
GB (1) GB2603645B (enExample)
TW (1) TWI862641B (enExample)
WO (1) WO2021016330A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12410143B2 (en) 2017-01-17 2025-09-09 Michael David FORREST Therapeutic inhibitors of the reverse mode of ATP synthase
BR112019028172A2 (pt) 2017-07-13 2020-10-06 Michael David Forrest moduladores terapêuticos do modo reverso da atp sintase
BR112022001229A2 (pt) 2019-07-22 2022-06-14 Octavio Franco Polipeptídeos tendo efeitos antissenescentes e usos dos mesmos
CN116549325B (zh) * 2022-01-27 2025-07-29 南京大学 一种组合物、其制备方法、制剂及应用
CN114560912B (zh) * 2022-03-28 2023-10-20 碧悦星泽(北京)生物医药科技有限公司 一种具有抗皱功能的多肽及其复合物与应用
CN115404257A (zh) * 2022-06-24 2022-11-29 江西师范大学 一种高通量快速筛选鱼鳞蛋白胶酪氨酸酶抑制肽的方法
CN115105423B (zh) * 2022-07-18 2023-12-22 深圳浦瑞健康科技有限公司 具有抗炎抗敏活性的组合物及其应用
AU2024257036A1 (en) * 2023-04-17 2025-10-16 Hysensbio Co., Ltd Novel use of cpne7 protein-derived peptide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009133098A2 (en) * 2008-04-29 2009-11-05 Dsm Ip Assets B.V. β-LACTAM PRODUCING STRAINS
WO2018199341A1 (ja) * 2017-04-28 2018-11-01 学校法人藤田学園 アレルギーの抗原およびそのエピトープ

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6033854A (en) 1991-12-16 2000-03-07 Biotronics Corporation Quantitative PCR using blocking oligonucleotides
WO1995006137A1 (en) 1993-08-27 1995-03-02 Australian Red Cross Society Detection of genes
JP2002539776A (ja) * 1999-03-23 2002-11-26 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４９個のヒト分泌タンパク質
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6180349B1 (en) 1999-05-18 2001-01-30 The Regents Of The University Of California Quantitative PCR method to enumerate DNA copy number
AU782102B2 (en) 1999-08-12 2005-07-07 Wisconsin Alumni Research Foundation Identification of genetic markers of biological age and metabolism
US6287778B1 (en) 1999-10-19 2001-09-11 Affymetrix, Inc. Allele detection using primer extension with sequence-coded identity tags
DE10130800B4 (de) 2001-06-22 2005-06-23 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität
WO2003060122A1 (en) 2001-12-21 2003-07-24 Diadexus, Inc. Compositions and methods relating to urinary specific genes and proteins
US20030207280A1 (en) 2002-05-06 2003-11-06 Hsiung Hsiao Determination of physiological conditions defined in traditional chinese medicine
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
WO2004108752A1 (en) * 2003-06-11 2004-12-16 Novozymes A/S Antimicrobial polypeptides
US20070259087A1 (en) 2003-06-11 2007-11-08 Novozymes A/S Antimicrobial Peptides
WO2005007129A2 (en) * 2003-07-17 2005-01-27 Angiotech International Ag Topical formulations with bioactive components
US20060107345A1 (en) * 2003-09-30 2006-05-18 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
CN1569220A (zh) 2004-04-23 2005-01-26 大连帝恩生物工程有限公司 基因重组抗真菌肽在治疗病原真菌感染上的应用
EP2230316A1 (en) 2005-02-01 2010-09-22 AB Advanced Genetic Analysis Corporation Nucleic acid sequencing by performing successive cycles of duplex extension
WO2008143679A2 (en) 2006-06-01 2008-11-27 Verenium Corporation Nucleic acids and proteins and methods for making and using them
WO2009097508A2 (en) * 2008-01-30 2009-08-06 Mcanulty, Jonathan Methods and compositions for wound healing
WO2009108713A2 (en) 2008-02-25 2009-09-03 Signum Biosciences, Inc. Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides
CA2734521A1 (en) 2008-08-28 2010-03-04 Dermtech International Determining age ranges of skin samples
GB0817121D0 (en) * 2008-09-18 2008-10-29 Univ St Andrews Anti-fungal therapy
JP2010115131A (ja) 2008-11-12 2010-05-27 Kao Corp 肌評価方法及び皮膚老化改善剤・皮膚老化予防剤のスクリーニング方法
KR101117195B1 (ko) 2009-07-27 2012-03-07 한국전기연구원 피부 노화도 측정장치 및 측정방법
WO2011026136A1 (en) 2009-08-31 2011-03-03 Life Technologies Corporation Low-volume sequencing system and method of use
WO2012162139A1 (en) 2011-05-20 2012-11-29 The Regents Of The University Of California Method to estimate age of individual based on epigenetic markers in biological sample
US9593363B2 (en) 2012-06-18 2017-03-14 The Procter & Gamble Company Methods and models for assessing anti-aging benefits of agents
US10329614B2 (en) 2013-08-02 2019-06-25 Stc.Unm DNA sequencing and epigenome analysis
CN105765083B (zh) 2013-09-27 2021-05-04 加利福尼亚大学董事会 基于表观遗传学标记物来估计组织和细胞类型的年龄的方法
WO2016118014A2 (en) 2015-01-23 2016-07-28 Erasmus University Medical Center Rotterdam Anti-senescence compounds and uses thereof
AU2016341309A1 (en) * 2015-10-22 2018-06-07 Modernatx, Inc. Cancer vaccines
GB201602918D0 (en) * 2016-02-19 2016-04-06 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers
US20190078162A1 (en) 2017-09-14 2019-03-14 OneSkin Technologies, Inc. In vitro methods for skin therapeutic compound discovery using skin age biomarkers
BR112022001229A2 (pt) 2019-07-22 2022-06-14 Octavio Franco Polipeptídeos tendo efeitos antissenescentes e usos dos mesmos

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009133098A2 (en) * 2008-04-29 2009-11-05 Dsm Ip Assets B.V. β-LACTAM PRODUCING STRAINS
WO2018199341A1 (ja) * 2017-04-28 2018-11-01 学校法人藤田学園 アレルギーの抗原およびそのエピトープ

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides;William F Porto，等;《Biochimica et Biophysica Acta (BBA)》;20180930;第1862卷(第9期);全文 *
生物活性多肽护肤品的基础及应用;李校坤，等;《日用化学工业》;20021020;第32卷(第5期);全文 *

Also Published As

Publication number Publication date
JP2022541845A (ja) 2022-09-27
KR20230096914A (ko) 2023-06-30
US20240342290A1 (en) 2024-10-17
GB2603645B (en) 2023-03-01
JP2025123221A (ja) 2025-08-22
US12268747B2 (en) 2025-04-08
EP4004021A2 (en) 2022-06-01
EP4004021B1 (en) 2025-09-03
WO2021016330A3 (en) 2021-03-04
TW202118508A (zh) 2021-05-16
US20250235542A1 (en) 2025-07-24
GB202200959D0 (en) 2022-03-09
TWI862641B (zh) 2024-11-21
GB2603645A (en) 2022-08-10
BR112022001229A2 (pt) 2022-06-14
US20210038729A1 (en) 2021-02-11
US12268746B2 (en) 2025-04-08
CN114729015A (zh) 2022-07-08
WO2021016330A2 (en) 2021-01-28
ES3049051T3 (en) 2025-12-12
EP4004021A4 (en) 2023-09-27

Similar Documents

Publication Publication Date Title
CN114729015B (zh) 具有抗衰老效果的多肽及其用途
US20220193061A1 (en) Method of treating a skin condition
Lee et al. Oral intake of collagen peptide NS improves hydration, elasticity, desquamation, and wrinkling in human skin: a randomized, double-blinded, placebo-controlled study
JP2002193738A (ja) 皮膚老化の徴候を処置する組成物における、少なくとも１種のツツジ科植物の少なくとも１種の抽出物の使用
KR20070003907A (ko) 혈청 노화 인자 격리 제제 및 이를 위한 용도
KR20230074492A (ko) 피부 및/또는 점막의 편안함 개선 및/또는 비듬의 출현 개선을 위한 펩타이드의 신규 용도
WO2017009489A1 (en) Topical compositions
KR102315208B1 (ko) 폴리고눔 비스토르타 추출물의 미용 또는 피부과 용도
WO2017009485A1 (en) Topical compositions
US20240415757A1 (en) Animal-free cosmetic collagens
JP6840863B2 (ja) ポリγグルタミン酸を含有するアトピー性皮膚症状改善用の組成物
ES2827253T3 (es) Preparación cutánea externa antienvejecimiento
US20250352608A1 (en) Polypeptides having anti-inflammatory effects and uses thereof
KR102881437B1 (ko) 자하거 모사 화장료 조성물
KR100998920B1 (ko) 창상 치유용 피부 외용제 조성물
EP4565199A1 (en) Reduction of signs of skin aging
US9566222B2 (en) Peptidyl arginine deiminase 1 and/or 3 activator compounds in the epidermis and uses thereof
KR20200036730A (ko) 피부 턴오버 촉진 및 멜라닌 배출 촉진용 조성물
WO2025122503A1 (en) Banana stem sap compositions and methods of use thereof
EP4692110A1 (en) Peptide having lipolytic effect, and use thereof
WO2025259703A1 (en) Combinations of cocoa polyphenols and amino acids for personal care or treatment, and compositions and methods thereof
JP2022119185A (ja) 抗光老化のための薬剤及び美容方法，並びに抗光老化剤のスクリーニング方法
HK40010484A (en) Composition containing poly-gamma-glutamic acid for improving symptoms of atopic dermatitis
KR20170136338A (ko) 해삼가공부산물추출물을 함유하는 주름개선용 화장료 조성물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant